Market Overview

Benzinga's Top Upgrades, Downgrades For November 7, 2018

Share:

Top Upgrades

  • Cowen & Co. upgraded Target Corporation (NYSE: TGT) from Market Perform to Outperform. Target shares rose 1.1 percent to $86.51 in pre-market trading.
  • Morgan Stanley upgraded ABIOMED, Inc. (NASDAQ: ABMD) from Equal-Weight to Overweight. Abiomed shares rose 7.7 percent to $420.00 in pre-market trading.
  • Wedbush upgraded Spark Therapeutics Inc (NASDAQ: ONCE) from Underperform to Neutral. Spark Therapeutics shares rose 6.3 percent to $44.30 in pre-market trading.
  • Deutsche Bank upgraded RenaissanceRe Holdings Ltd. (NYSE: RNR) from Hold to Buy. RenaissanceRe shares rose 2.12 percent to close at $126.55 on Tuesday.
  • Analysts at Wells Fargo upgraded Northern Trust Corporation (NASDAQ: NTRS) from Market Perform to Outperform. Northern Trust shares rose 0.2 percent to $96.00 in pre-market trading.
  • Raymond James upgraded Noble Energy, Inc. (NYSE: NBL) from Market Perform to Outperform. Noble Energy shares rose 7.7 percent to $29.10 in pre-market trading.
  • Piper Jaffray upgraded Zions Bancorp (NASDAQ: ZION) from Neutral to Overweight. Zions Bancorp shares rose 1.09 percent to close at $49.19 on Monday.
  • SunTrust Robinson Humphrey upgraded Oasis Petroleum Inc. (NYSE: OAS) from Sell to Hold. Oasis Petroleum shares rose 3.1 percent to $10.18 in pre-market trading.
  • Morgan Stanley upgraded Progressive Corp (NYSE: PGR) from Equal-Weight to Overweight. Progressive shares closed at $69.78 on Tuesday.
  • RBC Capital upgraded Usa Compression Partners LP (NYSE: USAC) from Sector Perform to Outperform. USA Compression Partners shares closed at $14.18 on Tuesday.

 

Top Downgrades

  • RBC Capital downgraded Freeport-McMoRan Inc (NYSE: FCX) from Sector Perform to Underperform. Freeport-McMoRan shares rose 1.7 percent to $12.41 in pre-market trading.
  • Goldman Sachs downgraded GreenSky Inc (NASDAQ: GSKY) from Buy to Neutral. GreenSky shares rose 0.2 percent to $9.30 in pre-market trading.
  • JP Morgan downgraded MINDBODY Inc (NASDAQ: MB) from Overweight to Neutral. MINDBODY shares fell 21.1 percent to $25.75 in pre-market trading.
  • UBS downgraded Frontier Communications Corp (NASDAQ: FTR) from Neutral to Sell. Frontier Communications shares fell 14.5 percent to $4.50 in pre-market trading.
  • Cantor Fitzgerald downgraded AAC Holdings Inc (NYSE: AAC) from Overweight to Neutral. AAC Holdings shares rose 9.5 percent to $3.24 in pre-market trading.
  • William Blair downgraded Audentes Therapeutics Inc (NASDAQ: BOLD) from Outperform to Market Perform. Audentes Therapeutics shares rose 1.48 percent to close at $29.56 on Tuesday.
  • Nomura downgraded Infinera Corp. (NASDAQ: INFN) from Buy to Neutral. Infinera shares fell 26.7 percent to $4.57 in pre-market trading.
  • Credit Suisse downgraded Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) from Outperform to Neutral. Ironwood Pharmaceuticals shares closed at $12.78 on Friday.
  • JMP Securities downgraded Monroe Capital Corp (NASDAQ: MRCC) from Market Outperform to Market Perform. Monroe Capital shares fell 7.2 percent to $11.71 in pre-market trading.
  • Susquehanna downgraded Zillow Group Inc (NASDAQ: Z) from Neutral to Negative. Zillow shares fell 21.1 percent to $32.38 in pre-market trading.

 

Top Initiations

  • Analysts at Cantor Fitzgerald initiated coverage on Proteostasis Therapeutics Inc (NASDAQ: PTI) with an Overweight rating. The price target for Proteostasis Therapeutics is set to $21. Proteostasis Therapeutics closed at $6.84 on Tuesday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (AAC + ABMD)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AMTDMorgan StanleyUpgrades65.0
APOMorgan StanleyDowngrades34.0
ARMKBairdUpgrades44.0
CGMorgan StanleyDowngrades23.0
EIXEdward JonesDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Cowen: 5 Reasons Target Will Outperform

Top 3 Price Forecast - Bitcoin, Ethereum, Ripple: The Market Consolidates The Bullish Turn